To Screen or Not to Screen

To Screen or Not to Screen

When investigating HAI outbreaks, your decisions have significant consequences. Implementing disruptive precautionary measures without confirming clonality can be costly and unnecessary. But failing to deal with real outbreaks early can lead to patient safety concerns and financial penalties. EpiXact®, our rapid turnaround, whole-genome sequencing service for HAI investigations, provides you...

Sign-Up to Receive the Monthly SNPIT Newsletter